261 related articles for article (PubMed ID: 21181085)
1. Sublingual immunotherapy for treating respiratory allergy: a review on its effectiveness and suitability.
Incorvaia C; Fuiano N; Leo G
Clin Ter; 2010; 161(6):543-7. PubMed ID: 21181085
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
3. Economic aspects of sublingual immunotherapy.
Incorvaia C; Ariano R; Berto P; Ciprandi G; Leo G; Boccardo R; Scurati S; Frati F
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):27-30. PubMed ID: 19944007
[TBL] [Abstract][Full Text] [Related]
4. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.
Compalati E; Passalacqua G; Bonini M; Canonica GW
Allergy; 2009 Nov; 64(11):1570-9. PubMed ID: 19796205
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
Canonica GW; Passalacqua G
Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
[TBL] [Abstract][Full Text] [Related]
7. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
8. An evidence based overview of sublingual immunotherapy in children.
Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
10. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
11. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
[TBL] [Abstract][Full Text] [Related]
12. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland.
Brüggenjürgen B; Reinhold T
J Med Econ; 2018 Apr; 21(4):374-381. PubMed ID: 29271271
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety.
Passalacqua G; Canonica GW
Immunol Allergy Clin North Am; 2011 May; 31(2):265-77, ix. PubMed ID: 21530819
[TBL] [Abstract][Full Text] [Related]
15. Quality of life outcomes with sublingual immunotherapy.
Wise SK; Woody J; Koepp S; Schlosser RJ
Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
[TBL] [Abstract][Full Text] [Related]
16. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
Nichani JR; de Carpentier J
J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
Allergy; 2004 Nov; 59(11):1205-10. PubMed ID: 15461603
[TBL] [Abstract][Full Text] [Related]
19. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
20. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
Esch RE; Bush RK; Peden D; Lockey RF
Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
